Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

16.93USD
18 Jun 2018
Change (% chg)

$0.13 (+0.77%)
Prev Close
$16.80
Open
$16.88
Day's High
$17.17
Day's Low
$16.58
Volume
133,428
Avg. Vol
258,786
52-wk High
$28.49
52-wk Low
$11.12

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.32 December 19 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.57 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 8 6.47 50.00 0.00 0.00
Quarter Ending Sep-18 8 0.03 0.25 0.00 0.00
Year Ending Dec-18 8 7.47 55.00 0.00 3.27
Year Ending Dec-19 7 3.42 11.10 0.00 12.39
Earnings (per share)
Quarter Ending Jun-18 8 -0.32 1.04 -0.54 -0.57
Quarter Ending Sep-18 8 -0.54 -0.45 -0.65 -0.45
Year Ending Dec-18 8 -1.91 -0.24 -2.35 -2.25
Year Ending Dec-19 8 -2.24 -1.83 -2.56 -2.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.03 0.00 0.03 100.00
Quarter Ending Dec-17 0.02 0.00 0.02 100.00
Quarter Ending Sep-17 0.19 0.00 0.19 100.00
Quarter Ending Jun-17 0.02 0.00 0.02 100.00
Quarter Ending Mar-17 0.03 0.91 0.89 3,544.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6.47 6.47 0.34 0.20 0.00
Quarter Ending Sep-18 0.03 0.03 0.03 0.03 0.00
Year Ending Dec-18 7.47 7.47 0.72 0.68 3.27
Year Ending Dec-19 3.42 3.42 2.48 1.60 12.39

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 1 1
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 1 1
Year Ending Dec-19 0 0 0 1
Earnings